Dr. Simona Mirabela Balu, MD

Dr. Balu practices at Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois.

Dr. Balu's NPI, 1629362462, was assigned on June 8, 2011. Dr. Balu holds Illinois license 036136182.

Dr. Balu's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital, at 1000 N Westmoreland Rd, Lake Forest, IL 60045 in Lake County. The practice phone is (847) 234-5600.

Dr. Balu's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois. Dr. Balu is also affiliated with Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Balu to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Balu practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Balu's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Balu is licensed in Illinois.

CMS data shows 939 Medicare services from Dr. Balu across 6 procedure codes in 2024, for 319 Medicare patients. Medicare paid $79,159 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 319 Medicare patients who saw Dr. Balu in 2024. The largest group is 75 to 84, with 129 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Balu's median patient age at 75, with 53% women.

In 2024, Dr. Balu wrote 565 Medicare Part D claims for 169 patients. 82% of them were for generic drugs. CMS names the drug for 286 of them, across 14 drugs with 11 or more claims each, at $37,228 in total drug cost. In 2023, CMS named 186 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Balu for performance year 2024, reported through an alternative payment model (APM). Dr. Balu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Balu from 2 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $88.